Viewing Study NCT03134456


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2025-12-25 @ 9:22 PM
Study NCT ID: NCT03134456
Status: COMPLETED
Last Update Posted: 2024-12-03
First Post: 2017-04-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pembrolizumab for Metastatic NSCLC Patients Expressing PD-L1 Who Have Their Own PDX
Sponsor: Samsung Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module